branch of the 8 th cranial nerve. 7 Small tumors present with vestibular symptoms as tinnitus 18 and otological symptoms as hearing impairment which may not be noticed by the patients. 24 As the tumor grows and compresses the central nervous system, cranial nerve palsies, brain stem compression and hydrocephalus can gradually occur. This is when patients present to us in developing countries like Nepal, due to lack of awareness and accessibility to service-providers.
We do not have a national registry but the overall incidence of vestibular schwannoma has been reported as 1.09 per 100,000 population. 13 Unlike our clinical scenario, increasing availability and frequent use of magnetic resonance (MR) imaging have led to diagnosis of very small tumors worldwide, 8 with neurosurgeons successfully attempting hearing preservation.
Observation with neuro-radiological follow-up, microsurgical resection and stereotactic radiotherapy are the available treatment modalities. 1, 19 The three surgical approaches are retrosigmoid, translabrynthine and middle cranial fossa or subtemporal approaches; and though each of these have advantages and limitations, 11, 21 we routinely practice retrosigmoid approach in our centre.
Microsurgical excision of large vestibular schwannomas can be associated with serious complications and functional sequlae mainly in the form of facial nerve function, as chances of preserving serviceable hearing in large vestibular schwannomas is very low. The aim of our study was to evaluate the outcome of surgical management of vestibular schwannoma and to determine if the size of the tumor affected the facial nerve outcome.
Methods
Patients with tumors in the cerebello-pontine angle region operated between Baisakh 2066 to Chaitra 2073 (8 years) at the National Institute of Neurological and Allied Sciences, a 100-bed, tertiary care neuro centre in Kathmandu, Nepal was retrospectively analyzed.
Among them a detailed study of patients who were histopatholgically proven to have vestibular schwanomma was done. This study was approved by the ethical board of the institution. The demographic profi le of the patients, the presenting symptoms, the cranial nerve involvement, radiological investigations, surgical intervention and complications were analyzed. The size of the tumor was classifi ed according to the Koos classifi cation 12 on the basis of the maximum transverse diameter on MR imaging. Pure tone audiometry hearing assessment records where available were retrieved. Patients requiring CSF diversion procedures before and after surgery was assessed. The surgical approach to the tumor was routinely retrosigmoid but positioning varied from supine oblique, lateral park bench to sitting. For facial nerve preservation we used a two-channel Neurosign 100, a nerve monitoring system with electrodes embedded in the ipsilateral orbicularis oculi and orbicularis oris muscle. The surgical technique employed was intra-capsular dissection and avoiding the use of bipolar coagulation close to structures suspected to be the cranial nerves. The morbidity and mortality following the surgery was analyzed. The outcome of patients in terms of facial nerve preservation at six months post surgery as per the House and Brackmann (HB) 9 facial nerve grading system was determined. A Pearson's chi square (Fischer's Exact) test was done to see if the size of the tumor had any bearing on the facial nerve outcome at six months. Data entry and analysis was done using IBM SPSS (version 20; SPSS Inc., Chicago, IL, USA)
Results

Demographics
A total of 88 patients with cerebello-pontine angle (CPA) tumors were operated over eight years, averaging around 11 cases every year. Out of these, records of 84 patients could be retrieved. 57 out of the 84 tumors (69.5%) were schwannomas. Two of them as confi rmed by radiology were trigeminal schwanommas and the rest vestibular. Menigioma, epidermoid, arachnoid cyst accounted for the rest and there was a case each of plasmacytoma, manlignant peripheral nerve sheath tumor and ewing's sarcoma (Fig. 1) The mean age of the patients with vestibular schwannoma was 39.96 ± 10.95 years and they ranged from 22 years to 68 years. 25 
Clinical Features and Investigations
The most common symptoms were headache and hearing loss, present in 80% and 91.3% patients respectively. Tinnitus and vertigo were complained by 45.2% and 40.6% patients respectively. In Nepalese scenario, presentation was mostly late, when the tumor had grown to a large size with nearly half of the patients having visual symptoms and papilloedema documented in 42.1% of cases. Involvement of the 5 th cranial nerve and the lower cranial nerves were seen in 65% and 29.6% cases respectively.
The records of pure tone audiometry (PTA) could only be retrieved in 17 patients. PTA on the affected ear was < 30db in 2 (11.76%), 30-50dB in 5 (29.41%), 51-70 db (11.76%) and >70db in 8 (47.05%) patients. Speech discrimination study was not done in our centre.
The transverse, antero-posterior and the craniocaudal dimensions of the tumor were recorded from the MRI reports of the patients; and the largest transverse dimension was used for the Koos classifi cation. The mean tumor size was 4.32 ± 1.23 cms, the largest being 7.5 cm and the smallest 2 cm. 48 (84.2%) of the patients had tumor size more than 3cms (fi g. 2)
Surgical Intervention and Complications
As the patients presented late and had hydrocephalus and as many as 18 (31.57%) patients required a preoperative ventriculoperitoneal shunt on the contra-lateral side. In eight (14.04%) patients an external ventricular drain was placed immediately prior to the surgery. The duration of the surgery was noted from the anaesthetic chart, from the time of induction to recovery and it was 6.07 ± 1.72 hours.
Though trans-labryinthine and sub-temporal (middle fossa) approaches have their advantages, retrosigmoid approach was routinely employed at our centre. 43 (75.44%) patients were operated in supine oblique position, eight (14.03%) in lateral park-bench position with a hockey stick incision and six (10.53%) in sitting position.
The mean hospital stay was 25.44 ± 14.71 days. This long hospital stay is partly affected by the need of preoperative VP shunt in as many as 18 (31.57%) patients where the major surgery followed a week later once the patient recovered from the CSF diversion procedure.
Eight (14.04%) patients developed post operative hydrocephalus and had to be shunted. Nine (15.79%) patients developed pseudomenigocele at the operative side, all of whom responded completely with placement of lumbar drain for fi ve days. Two (3.5%) patients developed CSF fi stula, who were also treated with lumbar drain. The incidence of post operative meningitis could not be confi rmed by this retrospective study; as in the postoperative period antibiotics were empirically used when the patient's state and CSF analysis were dubious. Records showed the use of antimeningitic treatment in 14 (24.56%) patients; but this was not based on culture positivity. Post operative hematoma requiring re-exploration occurred in one patient. There were two (3.5%) mortalities. The fi rst was a 66 year old gentleman with recurrent right cystic vestibular schwannoma, who underwent a near total excision a week after ventriculo-peritoneal shunting. After prolonged surgery, the patient had cavity hematoma, which was evacuated the same night; but the patient expired a week later. Another was a 40 year old gentleman who was reported to have a 5 cm X 4 cm X 3.5 cm left CP angle mass, likely Glossopharyngeal Schwannoma. He was operated in a supine oblique position, a week after initial CSF shunting. Brain swelling occurred before the tumor could be reached. External ventricular drain had to be kept which had to be changed multiple times due to infection; the patient expired after 37 days of ICU stay.
Koos Classifi cation
Hearing and Facial nerve preservation
In the Nepalese setting, hearing preservation could never be our aim due to delayed presentation; however, we were able to preserve hearing in a patient with a 2.7 cm sized vestibular schwannoma, which has been reported as a case report elsewhere. 15 We then assessed the facial nerve outcomes of patients at or after six months. Facial nerve functions as per the House and Brackmann grading was done by authors PS and NK. Out of the 55 surviving patients, only 26 could be followed despite repeated attempts. Photographic recording of the facial nerve function was done whenever possible with adequate consent at rest, while smiling and while closing eyes. Tumors less than 3 cms (Koo's classifi cation; largest dimension) were grouped as small tumors and those more than 3 cms as large. Patients with HB grading of 3 or below (upto moderate dysfunction), i.e. those patients who did not have gross facial asymmetry and those that could close eyes completely on effort were regarded as good outcome. HB grade 4-6 were regarded as bad facial nerve outcomes. All patients, seven, with tumors less than 3 cm in size had good facial nerve outcome at 6 months; however 7 out of 19 patients with tumors larger than 3 cm had poor facial nerve outcome. (Figure  3 ) The fi ndings have been presented in the table below and a Fischer Exact test was done to test for statistical signifi cance. The p-value was 0.077, which approached signifi cance but was still clinically signifi cant.
Discussion
Lesions in the CPA may be lesions originating in the CPA, lesions primarily located in adjacent anatomical sites and extending to the CPA and intraventricular and brain stem pathologies showing exophytic expansion to the CPA. Vestibular schwannomas (80-94%), meningiomas (3 to 10%), Epidermoids (2-4%) are the common tumors occurring in the CPA; 3 the list however is exhaustive. In our series Schwannomas accounted for 69.5 % and meningiomas 18.3 %.
There have been many large series of vestibular schwannomas published worldwide with skewed demographic details as presentation to clinicians in different parts of the world differ, so does the management ranging from watchful waiting to microsurgical resection. We had an adult subgroup of patients with the oldest being 68 years and the youngest, a patient with NF2, 22 years. 
Figure 5: Cross tabulation of the size of the tumor with House and Brackmann facial nerve grading
The mean age was 39.96 ± 10.95 years and 56.14% were females. In Sami's series of 1000 patients 54 percent were females and the mean age of the patients was in the mid forties. 18 NF2 accounted for two (3.5%) cases in our series and it was 6.6% of 7017 patients operated elsewhere.16 These patients presented early, required multiple operation; hence our practice was to delay surgery as long as the patient had some useful hearing. According to Sami's series, the most frequent clinical symptoms were disturbances of the acoustic (95%), vestibular (61%), trigeminal (9%), and facial (6%) nerves. 18 In our series, however, patients presented late with papilloedema documented in 42.1% of cases and many presenting with involvement of Trigeminal (65%) and the lower cranial nerves (29.6%).
Our review had some limitations. We were unable to elicit details regarding the extent of excision from the retrieved records. Sub-total resection, gross total resections were not adequately recorded; however, in most patients, total excision of the tumor with drilling of the internal auditory canal was attempted by senior author UPD. Post-operative MR imaging was not done routinely to lessen the fi nancial burden to family, so we are not able to document the extent of resection. Anatomical intactness of the facial nerve at the end of the surgery was also not adequately recorded. In a series of 979 tumors operated by Sami, 23major neurological complications included a case of tetraparesis, 10 cases of hemiparesis, and caudal cranial nerve palsies in 5.5% of the cases. Operative site hematoma occurred in 2.2%, cerebrospinal fl uid fi stulas in 9.2%, hydrocephalus in 2.3%, bacterial meningitis in 1.2%, and wound revisions in 1.1%. We had one (1.8%) operative site hematoma, two (3.5%) CSF fi stulas, hydrocephalus in eight (14%) and pseudomeningocele in nine (15.79%). Though antimeningitic treatment was used in 14 (24.56%) patients postoperatively, we were unable to identify the incidence of true bacterial meningitis. In Sami's series, there were 11 deaths occurring at 2 to 69 days postoperatively (1.1%); we lost two patients (3.5%) one following operative site hematoma and another to unexplained brain swelling before the tumor could be reached.
Hearing preservation could never be our aim as 84.2% of patient presented to us after the tumor had grown beyond 3 cms. We still do not do speech discrimination study at our centre, a sign that our priorities in vestibular schwanomma surgery differs for many centers worldwide attempting hearing preservation. Hopefully, in the years to come, with greater public awareness and earlier referral from ENT surgeons, we will be able to move in the right direction. A rare case where we could preserve hearing in a patient with a 2.7 cm vestibular schwanomma keeps us reminding this fact. 15 We were able to document the facial nerve outcome at 6 months of only 26 of the 57 (45.6%) patients; as patients operated at our centre were from various places all over the country. Among them, seven patients who had tumors less than 3 cms, all had good outcome (HB grade I to III). 12 out of 19 patients who had tumors larger than 3cms also had good outcome; the rest 7 did not do well. Facial-hypoglossal anastomosis was attempted in one of these patients; but he too did not have a good outcome. Fischer exact test could not, however, establish statistical signifi cance; though our fi ndings suggest, facial nerve preservation is more diffi cult with larger tumors. Bloch O et al. found out that only preoperative tumor size predicted the facial nerve outcome signifi cantly; age, extent of resection, surgical approach did not.2 Kim J et al. also agree with the fact that preoperative size of the tumor is one of the most important prognostic factors; but surgeon's experience and preoperative facial nerve injury by the tumor can affect the post operative facial nerve outcome. 10 The facial nerve outcome during resection of large vestibular schwannomas has been variously reported in literature. Mild facial nerve weakness (HB grade I and II) only, when tumors larger than 3cm were operated was seen in 52.6 % of 178 patients by Lanmann et al. We were unable to analyze the difference in preservation of facial nerve in the solid and cystic varieties of the vestibular schwannoma, due to inadequate recording. A study by Thakur JD et al. concluded facial nerve outcomes were signifi cantly better in the cohort of patients with solid Vestibular Schwannomas (SVSs) than in those with cystic Vestibular Schwannomas ( CVSs) (52.1% vs 39%, p = 0.0001) 26. In another study by Tang IP et al there was no such difference noted. Postoperative facial nerve outcomes at 1-year follow-up were good (HB Grade I-III) in 116 (88.5%) of 131 cystic Vestibular Schwannoma 118 (90.1%) of 131 solid Vestibular Schwannoma. 25
Outcome in vestibular schwannoma
Conclusion
Retrosigmoid approach is a versatile surgical corridor to excise large vestibular schwannomas with minimal complications. Small tumors < 3cm can be safely microsurgically excised with good facial nerve outcomes; however, lack of awareness and accessibility to serviceproviders, cause patients to present late, endangering the facial nerve function and making hearing preservation next to impossible in Nepalese context.
